As ETV6 is a ubiquitously expressed transcriptional repressor, which was shown to form fusion genes with oncogenic consequences in a number of hematological malignancies and solid tumors [66, 67], it would be crucial to determine whether BCL2L14-ETV6 fusion occurs in other types of cancer. Here, ETV6 is linked to hematologic disorder.